The primary outcome measure for the study was the difference in average stool consistency in the last 2 weeks of treatment of ondansetron versus placebo, and this showed a highly significant improvement with active treatment.
← all excerpts
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial.
1
—
—